Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana

To assess misoprostol availability at community pharmacies and determine factors affecting misoprostol prescription for medical abortion.

[1]  A. Bankole,et al.  The impact of Ghana’s R3M programme on the provision of safe abortions and postabortion care , 2014, Health policy and planning.

[2]  L. Reichenbach,et al.  Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[3]  J. Anim,et al.  Pregnancy related causes of deaths in Ghana: a 5-year retrospective study. , 2013, Ghana medical journal.

[4]  S. Mayhew,et al.  Shaping legal abortion provision in Ghana: using policy theory to understand provider-related obstacles to policy implementation , 2013, Health Research Policy and Systems.

[5]  B. Levandowski,et al.  Misoprostol provision through community pharmacy and licensed chemical shops in Ghana , 2012 .

[6]  I. Shah,et al.  Expanding access to medical abortion: Perspectives of women and providers in developing countries , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  B. Winikoff,et al.  Use of medicines changing the face of abortion. , 2012, International perspectives on sexual and reproductive health.

[8]  D. Billings,et al.  Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: A review of the literature , 2012, Journal of Public Health Policy.

[9]  D. Lauro.  Abortion and contraceptive use in sub-Saharan Africa: how women plan their families. , 2011, African journal of reproductive health.

[10]  Susheela Singh,et al.  Methodologies for estimating abortion incidence and abortion-related morbidity: a review. , 2010 .

[11]  S. García,et al.  Misoprostol use and its impact on measuring abortion incidence and morbidity. , 2010 .

[12]  I. Masood,et al.  The role of pharmacists in developing countries: the current scenario in Pakistan , 2009, Human resources for health.

[13]  Nawal M. Nour,et al.  Unsafe abortion: unnecessary maternal mortality. , 2009, Reviews in obstetrics & gynecology.

[14]  R. Allen,et al.  Uses of misoprostol in obstetrics and gynecology. , 2009, Reviews in obstetrics & gynecology.

[15]  Jun Zhang,et al.  Medical abortion and the risk of subsequent adverse pregnancy outcomes. , 2007, The New England journal of medicine.

[16]  K. Abuabara,et al.  Pharmacy provision of medical abortifacients in a Latin American city. , 2006, Contraception.

[17]  F. Smith.  Community pharmacy in Ghana: enhancing the contribution to primary health care. , 2004, Health policy and planning.

[18]  M. Creinin.  Medical abortion regimens: historical context and overview. , 2000, American journal of obstetrics and gynecology.

[19]  Leopold Schmetterer,et al.  Elementary Sampling Theory , 1974 .